BDA advises TE Asia on sale of HKIOC to New Frontier

BDA Partners is pleased to announce that its client, TE Asia Healthcare Partners (“TE Asia”), a portfolio company of TPG Capital, has agreed to sell its stake in Hong Kong Integrated Oncology Centre Limited (“HKIOC”) to NF Nestor Investment Holding Limited (“New Frontier”).

BDA Partners acted as exclusive financial advisor to TE Asia and HKIOC’s other shareholders on the transaction.

HKIOC is the largest pure-play private oncology group in Hong Kong, with more than 80 staff, including 14 oncologists and radiologists, across three clinics.

New Frontier is one of the largest and fastest growing integrated healthcare service providers in China.

Antony Leung, Co-founder and Chairman of New Frontier Group, said, “Given the chronic and growing demand for quality cancer care in China, I’m grateful that we have found a partner who is not only a sector leader but also shares our corporate mission of Doing good and Doing Well, with Love.”

Prof. Ronnie Poon Tung-Ping, Founder of HKIOC, said, “I am thrilled that HKIOC has joined New Frontier Group, a moment that fills entire team with tremendous pride. This partnership is a recognition of our accomplishments and growth as a comprehensive oncology diagnostic and medical centre since our establishment in 2015. The integration into New Frontier presents a significant opportunity to contribute to the medical development of the Greater Bay Area, and I hope our centres, along with the entire group, can lay a solid foundation in oncology for decades to come.”

Sophia Wu, Managing Director and Head of Healthcare China, BDA, said, “We’re pleased to have found HKIOC a new partner and set the stage for its next phase of growth with New Frontier. This transaction further showcases BDA’s expertise in the Asian healthcare service sector.”

TE Asia and HKIOC’s other shareholders were also advised by Robertsons (legal) and KPMG (financial).